Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-006925
Filing Date
2021-06-03
Accepted
2021-06-03 18:30:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 31613
2 filename2.txt TEXT-EXTRACT 6538
  Complete submission text file 0000000000-21-006925.txt   50715
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filed for) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)